SELECT COUNTRY

VIEW ALL
AFRICA
AMERICAS
ASIA
EUROPE
OCEANIA

CANADA: LATEST INTERVIEWS MORE INTERVIEWS

Daniel Tellechea
INTERIM CEO, LARGO INC.
"We produce approximately 7% of the global vanadium supply, and on the titanium side, we are expected to produce about two thirds of the Brazilian demand for titanium pigment once the project reaches full capacity."
Mining
Canada
Eric Smith
MANAGING DIRECTOR, CEMENTATION
"Ontario has one of the highest densities of expertise in underground mining out of any of the jurisdictions we work in."
Mining
Canada
Marco Prud’Homme
PRESIDENT, NOLINOR AVIATION
"For the next 20 years, there will be lots of exploration and development in a region where there are few roads and limited sea access. So, aviation will play a crucial role in the green transition."
Mining
Canada
Dustin Angelo
PRESIDENT, CEO AND CO-FOUNDER, NOVAMERA
"There is a huge economic benefit for companies to be able to get that incremental production, because they already have all the infrastructure in place, including people, permits and mills."
Mining
Canada

CANADA: LATEST ARTICLES

Mining
Canada

The Battery Material Supply Chain

February 15, 2022
How the mining sector will play a pivotal role in determining the world's climate change and green revolution outcomes.
Mining
Canada

Industry Thoughts on Battery Metals

February 15, 2022
Ontario’s battery metal juniors share their opinions.
Mining
Peru
Canada

The Global Tailings Standard

April 16, 2021
The mining industry and investment community are collaborating to mitigate a perpetual risk, after a series of high-profile disasters.
MORE ARTICLES

CANADA: RECENTLY RELEASED PUBLICATIONS

Mining in Ontario and Toronto's Global Reach 2023 - Digital Interactive

May 04, 2023

Mining in Ontario and Toronto's Global Reach 2023

February 23, 2023

Mining in Ontario and Toronto’s Global Reach 2023 Pre-Release

November 21, 2022

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Life Sciences 2023

In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL